LinkedIn Live: Smarter trials, stronger Europe. New targets for clinical research., European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 September 2025, 14:00 (CEST) to 24 September 2025, 15:00 (CEST)

Submitted by Anonymous (not verified) on 16 September 2025 - 8:36

LinkedIn Live: Smarter trials, stronger Europe. New targets for clinical research., European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 September 2025, 14:00 (CEST) to 24 September 2025, 15:00 (CEST)

Human medicines European public assessment report (EPAR): Baqsimi, glucagon, Date of authorisation: 16/12/2019, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 15 September 2025 - 16:27

Human medicines European public assessment report (EPAR): Baqsimi, glucagon, Date of authorisation: 16/12/2019, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Emselex, darifenacin hydrobromide, Date of authorisation: 22/10/2004, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 15 September 2025 - 16:02

Human medicines European public assessment report (EPAR): Emselex, darifenacin hydrobromide, Date of authorisation: 22/10/2004, Revision: 28, Status: Authorised

Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases

Submitted by Anonymous (not verified) on 15 September 2025 - 14:23

Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More